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Introduction: The prognostic impact of acute kidney injury (AKI) on long-term clinical outcomes remains
controversial. We examined the five-year risk of death, myocardial infarction, and stroke after elective cardiac surgery
complicated by AKI.
Methods: We conducted a cohort study among adult elective cardiac surgical patients without severe chronic
kidney disease and/or previous heart or renal transplant surgery using data from population-based registries. AKI
was defined by the Acute Kidney Injury Network (AKIN) criteria as a 50% increase in serum creatinine from baseline
level, acute creatinine rise of ≥26.5 μmol/L (0.3 mg/dL) within 48 hours, and/or initiation of renal replacement therapy
within five days after surgery. We followed patients from the fifth post-operative day until myocardial infarction, stroke
or death within five years. Five-year risk was computed by the cumulative incidence method and compared with
hazards ratios (HR) from a Cox proportional hazards regression model adjusting for propensity score.
Results: A total of 287 (27.9%) of 1,030 patients developed AKI. Five-year risk of death was 26.5% (95% CI: 21.2 to 32.0)
among patients with AKI and 12.1% (95% CI: 10.0 to 14.7) among patients without AKI. The corresponding adjusted HR
of death was 1.6 (95% CI: 1.1 to 2.2). Five-year risk of myocardial infarction was 5.0% (95% CI: 2.9 to 8.1) among patients
with AKI and 3.3% (95% CI: 2.1 to 4.8) among patients without AKI. Five-year risk of stroke was 5.0% (95% CI: 2.8 to 7.9)
among patients with AKI and 4.2% (95% CI: 2.9 to 5.8) among patients without AKI. Adjusted HRs were 1.5
(95% CI: 0.7 to 3.2) of myocardial infarction and 0.9 (95% CI: 0.5 to 1.8) of stroke.
Conclusions: AKI, within five days after elective cardiac surgery, was associated with increased five-year mortality and a
statistically insignificant increased risk of myocardial infarction. No association was seen with the risk of stroke.Introduction
Acute kidney injury (AKI) occurs in up to 30% of pa-
tients undergoing cardiac surgery and has been reported
to be associated with increased mortality [1,2]. AKI is
defined as an abrupt decline of kidney function with se-
verity ranging from mild kidney dysfunction to complete
renal failure with the need for acute dialysis. Recent clas-
sification systems divide AKI into three severity levels* Correspondence: mkhansen88@gmail.com
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reproduction in any medium, provided the orbased on changes in serum creatinine level and/or urine
output [3].
Previous studies in cardiac surgical patients have mainly
focused on severe AKI requiring dialysis [4]. Lately, focus
has shifted towards the mortality impact of less severe
AKI as defined by either Risk, Injury, Failure, Loss of func-
tion, and End-stage renal disease (RIFLE) or Acute Kidney
Injury Network (AKIN) criteria. Only three studies have
examined the long-term prognosis (that is, beyond 90
days) of cardiac surgery complicated by less severe AKI
[5-7]. These studies have found that AKI is associated with
a 40 to 50% increase in long-term mortality and that AKILtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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cardiac events compared to patients without AKI. The
studies were limited by baseline serum creatinine being
estimated by the Modification of Diet in Renal Disease
equation rather than measured, inclusion of both acute
and elective surgical patients, and incomplete follow-up
data [6,7].
More insight into the prognostic role of AKI in elect-
ive cardiac surgical patients is needed, as AKI occurs fre-
quently and may have devastating consequences for the
patient. Increased awareness of AKI could, therefore, po-
tentially facilitate a more prophylactic treatment strategy
among high-risk patients.
We, therefore, conducted a cohort study of elective
cardiac surgical patients with detailed pre-, peri- and
post-operative information to examine the prognostic
role of early AKI on long-term risk of major adverse




We conducted the study at the Department of Cardio-
thoracic and Vascular Surgery, Aarhus University Hos-
pital, Denmark. The hospital provides cardiac surgery
for a mixed rural-urban population of approximately 1.2
million inhabitants (20% of the total Danish population)
in the Central Denmark Region. The Danish National
Health Service provides tax-funded medical care for all
Danish residents. Due to the unique Central Personal
Registry number assigned to each Danish citizen at birth
and to residents on immigration, it is possible to make
accurate linkage to patient and registries at an individual
level [8]. The study was approved by the Danish Data
Protection Agency and the Regional Ethics Committee
(record number: 2013-41-1516).
Elective cardiac surgical patients
During the period from 1 April 2005 to 8 October 2007,
a total of 2,215 patients underwent acute and elective
cardiac surgery at the Department of Cardiothoracic and
Vascular Surgery, Aarhus University Hospital, Denmark.
Patient screening and recruitment was done with the
assistance of a project nurse working half-time, thus
approximately 50% of the total population could be
screened consecutively. Patients were included in the
study database on the basis of: 1) age (≥18 years old);
and 2) elective cardiac surgery (surgery performed more
than two days after planning the procedure) including
valve surgery, on- and off-pump coronary artery bypass
grafting, thoracic aortic surgery, pulmonary thromboen-
darterectomy, ventricular aneurysm, adult congenital
heart disease procedures, or combined procedures. Exclu-
sion criteria were: 1) severe pre-existing chronic kidneydisease (serum creatinine >200 μmol/L (2.3 mg/dL)); and/
or 2) previous heart or renal transplant surgery. The nurse
prospectively collected information and completed a case-
report-form for each patient included in the study con-
taining baseline characteristics such as: smoking; body
mass index (BMI); diabetes mellitus; dyslipidemia; blood
pressure, and in-hospital peri-operative information. Every
patient included in the study gave their informed consent
to participate.
Acute kidney injury
We used the regional laboratory database to obtain pre-
and post-operative laboratory measurements. This
population-based database contains information on all
patient tests analyzed since 1997, including analyses
codes, measurement units, dates of test collection and
results [9]. Measurements of plasma creatinine - equiva-
lent to serum creatinine - were used to classify patients
as either AKI or non-AKI according to the serum cre-
atinine criteria in the AKIN classification [3,10]. We did
not include the urine output criteria. The term AKI in-
cluded all AKIN stages, and was further subdivided ac-
cording to the individual AKIN stages. For each patient,
a pre-operative blood sample was collected 10 days prior
to surgery. Accordingly, the baseline creatinine was
available for all study participants. The peak post-
operative measurement of creatinine from surgery start
until day five was compared to baseline creatinine to as-
sign AKI status.
Study endpoints
Information on all-cause death was obtained through
linkage to the Danish Civil Registration System [8].
This system includes information on all changes in
vital status, migration and exact date of death for the
Danish population since 1968 and is electronically
updated daily.
Causes of death (both immediate and underlying)
were studied through linkage to the Danish Registry of
Causes of Death, which contains date and causes of
death according to the International Classification of
Diseases 10th revision (ICD-10) classification (Additional
file 1) [11].
Data regarding myocardial infarction and stroke (in-
cluding both ischemic and hemorrhagic stroke) were
obtained from the Danish National Registry of Patients
(DNRP) (Additional file 1) [12]. The DNRP is a nation-
wide registry established in 1977 and includes civil regis-
tration number, hospital, department, discharge diagnosis,
as well as surgical and diagnostic procedures. Since
1994, diagnoses have been coded using the ICD-10. We
included all first-time hospitalizations with a discharge
diagnosis of the specified outcome, occurring after
index admission for surgery. Date of diagnosis was
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patient visits). Outcomes occurring during index admission
for surgery, that is, from admission date until discharge
date, were excluded for the concerned analysis.
Covariates
Information on potential confounding factors was ob-
tained from a pre-operative interview and medical re-
cords [13]. The included covariates were gender, age,
smoking habits (present, never, previous), BMI, history
of ischemic peripheral disease, previous stroke, previous
myocardial infarction, history of arrhythmias, diabetes,
dyslipidemia and hypertension. In addition, we obtained
data on pre-existing comorbidity based on diagnoses
from the DNRP (ICD-8 and ICD-10) since 1977 to com-
pute the Charlson Comorbidity Index (CCI) scores. The
CCI includes 19 disease categories with an assigned
weight, and the sum of the weights defines the level of
comorbidity. Patients were categorized as having low
(score 0), medium (score 1 to 2) and high (score ≥3)
levels of comorbidity (Additional file 2) [14]. The
Western Denmark Heart Registry established in 1999
is a regional administrative and clinical register in-
cluding detailed records on baseline patient character-
istics and data regarding all cardiac procedures as well
as corresponding covariates [15]. From this registry we
obtained procedural characteristics including type of
surgery, extra-corporal circulation and the EuroSCORE
(European System for Cardiac Operative Risk Evaluation).
The EuroSCORE assigns the patient an operative mor-
tality risk based on patient-, cardiac- and operation-
related factors [16].
Statistical analyses
We followed patients from day five after surgery (that is,
after assignment of AKI status) until death or emigration
occurred or up to five years.
For the full cohort the cumulative incidence method
was used to compute one- and five-year absolute risk of
death, myocardial infarction and stroke. Death was con-
sidered a competing risk in the estimation of the risk of
myocardial infarction and stroke. We computed five-
year unadjusted and adjusted hazard ratios (HRs) for
death, myocardial infarction and stroke using a Cox pro-
portional hazards regression model. The assumption of
proportional hazards was examined graphically and ful-
filled for the whole time period and for every outcome.
We computed a propensity score, which predicted the
probability of developing AKI conditional on the observed
baseline covariates, using multivariable logistic regression.
Modeling the exposure, rather than the outcome propen-
sity scores, efficiently allows for simultaneous control for a
large number of potentially confounding factors in studies
such as ours where we have few outcomes but manyexposed [17]. The included covariates were: gender, age,
smoking, BMI, history of ischemic peripheral disease,
previous stroke, previous myocardial infarction, history
of arrhythmias, diabetes mellitus, dyslipidemia, hyper-
tension, CCI, baseline creatinine, EuroSCORE, type of
surgical procedure (valve, Coronary Artery Bypass Graft-
ing (CABG), combined valve and CABG, others), and
extra corporal circulation.
In the analyses of the full cohort, the HR was adjusted
for the propensity score as a continuous variable. Fur-
thermore, we performed a propensity score matched
analyses which aimed to match each AKI patient with
the non-AKI patient with the nearest propensity score
within a maximum caliper range of ± 0.025 and without
replacement. In this manner we were able to match 257
(89.5%) of 287 AKI patients with a non-AKI patient. Co-
variates were adequately balanced after propensity score
matching, as evidenced by a standardized difference of
each covariate to values below 0.1 [18]. In the matched
cohort we also computed the cumulative risk and HRs
for each outcome, stratified on the matched pairs.
We examined the causes of death for the full cohort,
including both immediate and underlying causes of
death. Hence, a patient may be registered with more
than one cause of death. Causes were listed in disease
categories and estimates given as percentages of the total
number of causes of death according to AKI status.
Analyses were performed using the statistical software
package Stata® 12.0 package (StataCorp LP, College
Station, TX, USA).
Results
The study population comprised 1,030 patients (Figure 1).
A total of 27.9% (287 of 1,030) had an episode of AKI dur-
ing the first five post-operative days; these included 82.9%
(238 of 287) of patients in AKI stage 1 and 17.1% (49 of
287) of patients in AKI stage 2 or 3. AKI patients were
older, more likely to have a history of stroke, arrhythmias
and diabetes, had a higher comorbidity score and a higher
EuroSCORE. Mean baseline creatinine was 94.2 μmol/L
for AKI patients and 81.4 μmol/L for non-AKI patients
(Table 1). In the matched cohort the covariates were
equally distributed.
Three patients emigrated during follow-up. Total follow-
up time was 4,699 person-years with a median duration of
five years. In the full cohort, a total of 166 patients died
during the five years of follow-up (76 AKI patients and 90
non-AKI patients). We found a five-year cumulative risk
of death of 26.5% (95% CI: 21.2 to 32.0) among AKI pa-
tients compared with 12.1% (95% CI: 10.0 to 14.7) among
non-AKI patients. Adjusted HR was 1.6 (95% CI: 1.1 to
2.2). When stratifying according to AKI stage we found a
progressively higher mortality with advancing AKI stage:
Five-year cumulative risk of death in AKI stage 1 of 24.8%
Figure 1 Flowchart.
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(95% CI: 23.2 to 49.7) (Figure 2). The adjusted HRs were
1.4 (95% CI: 1.0 to 2.1) for AKI stage 1 and 2.3 (95% CI:
1.4 to 3.9) for AKI stage 2 and 3 compared to non-AKI
patients (Table 2). In the matched cohort, we found a
five-year risk of death of 18.7% (95% CI: 14.5 to 24.1)
for non-AKI patients and 25.7% (95% CI: 20.8 to 31.5) for
AKI patients. The HR of death was 1.6 (95% CI: 1.1 to 2.4)
comparing AKI with non-AKI patients (Table 3, Figure 3).
When analyzing the risk of myocardial infarction, 35
non-AKI patients and 9 AKI-patients were excluded be-
cause they received their myocardial infarction diagnosis
during the index admission for surgery. We found a
five-year cumulative risk of myocardial infarction of
5.0% (95% CI: 2.9 to 8.1) among AKI patients and 3.3%
(95% CI: 2.1 to 4.8) among non-AKI patients. The ad-
justed HR was 1.5 (95% CI: 0.7 to 3.2) (Table 2). In the
matched cohort, we found similar five-year risks and a
HR of 1.1 (95% CI: 0.4 to 3.2) (Table 3).
When analyzing the risk of stroke, seven non-AKI pa-
tients and five AKI-patients were excluded due to receiv-
ing their stroke diagnosis during the index admission for
surgery. We found a five-year cumulative risk of stroke
of 5.0% (95% CI: 2.8 to 7.9) among AKI patients and
4.2% (95% CI: 2.9 to 5.8) among non-AKI patients. The
adjusted HR was 0.9 (95% CI: 0.5 to 1.8) for AKI patients
compared with non-AKI patients (Table 2). In thematched cohort, we found similar five-year risks and a
HR of 0.5 (95% CI: 0.2 to 1.2) (Table 3).
Heart disease was registered as cause of death in 55%
(95% CI: 45 to 66) of causes among AKI patients and
47% (95% CI: 37 to 57) of causes among non-AKI pa-
tients (Figure 4). Myocardial infarction was registered as
the cause of death in 10% (95% CI: 5 to 18) of causes
among AKI patients and 4% (95% CI: 1 to 9) of causes
among non-AKI patients. Kidney insufficiencies and
cerebrovascular diseases (including stroke) were equally
distributed between the two groups. Data on cause of
death were not available on seven patients.
We found that estimated Glomerular Filtration Rate
(GFR) was slowly declining in the follow-up period after
elective cardiac surgery (Additional file 3).Discussion
Key results
We found that more than one out of four adult elective
cardiac surgical patients without pre-existing severe kid-
ney impairment developed AKI according to the AKIN
criteria within five days after surgery. AKI was associated
with increased mortality up to five years after elective car-
diac surgery. Although statistically imprecise, AKI may be
associated with an increased risk of myocardial infarction,
but there was no association with the risk of stroke.
Table 1 Descriptive data of patients undergoing elective cardiac surgery in the full cohort and matched cohort
Full cohort Matched cohort
Totala AKIa non-AKIa AKIa non-AKIa
Clinical features n = 1,030 n = 287 n = 743 n = 257 n = 257
Pre-operative characteristics
Male gender 750 (72.8) 209 (72.8) 541 (72.8) 190 (73.9) 189 (73.5)
Age (years), mean (IQR) 65.8 (59 to 75) 70.0 (64 to 78) 64.1 (58 to 73) 69.4 (63 to 77) 69.3 (65 to 76)
Smoker
Present 487 (47.3) 147 (51.2) 340 (45.8) 130 (50.6) 129 (50.2)
Never 357 (34.7) 88 (30.7) 269 (36.2) 82 (31.9) 83 (32.3)
Previous 186 (18.1) 52 (18.1) 134 (18.0) 45 (17.5) 45 (17.5)
BMI (kg/m2)
<25 287 (27.9) 85 (29.6) 202 (27.2) 72 (28.0) 63 (24.5)
25 to 30 425 (41.3) 110 (38.3) 315 (42.4) 103 (40.0) 100 (38.9)
>30 318 (30.9) 92 (32.1) 226 (30.4) 82 (31.9) 94 (36.6)
Previous ischemic peripheral disease 57 (5.5) 19 (6.6) 38 (5.1) 17 (6.6) 13 (5.1)
Previous stroke 104 (10.1) 37 (12.9) 67 (9.0) 32 (12.5) 29 (11.3)
Previous myocardial infarction 256 (24.9) 66 (23.0) 190 (25.6) 63 (24.5) 65 (25.3)
History of arrhythmias 154 (15.0) 60 (20.9) 94 (12.7) 49 (19.1) 51 (19.8)
Diabetes mellitus 166 (16.1) 58 (20.2) 108 (14.5) 50 (19.5) 55 (21.4)
Dyslipidemia 570 (55.3) 156 (54.3) 414 (55.7) 141 (54.9) 147 (57.2)
Hypertension 585 (56.8) 166 (57.8) 419 (56.4) 146 (56.8) 153 (59.5)
Normal <140 and <90b 455 (44.2) 121 (42.2) 324 (43.6) 111 (43.2) 104 (40.5)
Grade I 140 to 159 or 90 to 99b 306 (29.7) 80 (27.9) 226 (31.4) 70 (27.2) 91 (23.7)
Grade II 160 to 179 or 100 to 109b 189 (18.4) 61 (21.3) 128 (17.2) 56 (21.8) 42 (16.3)
Grade III > =180 or > =110b 90 (8.7) 25 (8.7) 65 (8.8) 20 (7.8) 20 (7.8)
Charlson comorbidity index
Low (score 0) 396 (38.5) 91 (31.7) 305 (41.5) 86 (33.5) 91 (35.0)
Medium (score 1 to 2) 456 (44.3) 135 (47.0) 321 (43.2) 119 (46.3) 112 (43.6)
High (score >3) 178 (17.3) 61 (21.3) 117 (15.7) 52 (20.2) 54 (21.0)
Baseline creatinine (μmol/L), mean (IQR) 85.0 (68 to 98) 94.2 (73 to 109) 81.4 (66 to 92) 90.9 (72 to 107) 91.3 (73 to 105)
euroSCORE, mean (IQR)c 5.2 (3 to 7) 6.4 (4 to 8) 4.7 (3 to 7) 6.1 (4 to 8) 6.1 (4 to 8)
Low risk (score 0 to 2) 199 (19.3) 30 (10.5) 169 (22.8) 30 (11.7) 28 (10.9)
Medium risk (score >2 to 5) 369 (35.8) 82 (28.6) 287 (38.6) 78 (30.4) 81 (31.5)
High risk (score >5) 462 (44.9) 175 (70.0) 287 (38.6) 149 (58.0) 148 (57.6)
Surgical procedure characteristics
Type of surgery
Valved 313 (30.4) 84 (29.3) 229 (30.8) 77 (30.0) 78 (30.4)
CABG 372 (36.1) 85 (29.6) 287 (38.6) 80 (31.1) 71 (27.6)
Valve and CABG 158 (15.3) 59 (20.6) 99 (13.3) 51 (19.8) 54 (17.1)
Othere 187 (18.2) 59 (20.6) 128 (17.2) 49 (19.1) 54 (17.1)
Extra corporal circulation 910 (88.4) 255 (88.9) 655 (88.2) 227 (88.3) 223 (86.8)
aValues are expressed as counts (percentage) unless otherwise indicated.
bMeasured in mmHg.
cEuroSCORE: A risk score for the operative mortality.
dValve: Aorta, mitral, tricuspidal.
eOther: Pulmonary valve surgery, coarctatio, subvalvular membrane, ventricular aneurysme, ventricular septum defect, atrial septum defect, pulmonary
thromboendatrerectomi, thoracic aorta.
AKI, Acute Kidney Injury; BMI, Body Mass Index; CABG, Coronary Artery Bypass Grafting; IQR, Interquartile Range.
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Figure 2 Kaplan Meier curve illustrating the five-year risk of death in the full cohort.
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Only three studies have examined the long-term impact
of RIFLE/AKIN defined AKI following cardiac surgery
[5-7]. In a US cohort of 2,973 acute and elective cardio-
thoracic surgical patients, a total of 1,265 patients (43%)
experienced an episode of AKI during admission. They




Endpoint n n % (95% CI)
Death
Non-AKI 90 743 2.3 (1.4 to 3.7)
AKI 76 287 9.4 (6.6 to 13.4)
Stage 1 59 238 8.8 (5.8 to 13.2)
Stage 2 + 3 17 49 12.2 (5.7 to 25.2)
Myocardial infarction
Non-AKI 23 708 1.4 (0.7 to 2.5)
AKI 14 278 1.8 (0.7 to 3.9)
Stage 1 11 230 1.7 (0.6 to 4.1)
Stage 2 + 3 3 48 2.1 (0.2 to 9.6)
Stroke
Non-AKI 31 736 1.6 (0.9 to 2.8)
AKI 14 282 2.1 (0.9 to 4.4)
Stage 1 10 236 1.8 (0.7 to 3.9)
Stage 2 + 3 4 46 2.1 (0.9 to 4.4)
aAdjusted for propensity score.
AKI, Acute Kidney Injury; CI, Confidence Interval.1.23 to 1.57) [6]. They observed a higher proportion of
patients who developed AKI compared to our findings
(27.9%), which may partly be explained by the estimation
of baseline creatinine by the Modification of Diet in
Renal Disease equation rather than measuring creatin-
ine. Studies have reported that the Modification of Diet
in Renal Disease equation overestimates the incidence ofstroke by AKI status in the full cohort
Five-year risk Hazard ratio
Crude Adjusteda
% (95% CI) (95% CI) (95% CI)
12.1 (10.0 to 14.7) 1 (reference) 1 (reference)
26.5 (21.2 to 32.0) 2.4 (1.8 to 3.3) 1.6 (1.1 to 2.2)
24.8 (19.8 to 30.8) 2.3 (1.6 to 3.1) 1.4 (1.0 to 2.1)
34.7 (23.2 to 49.7) 3.4 (2.0 to 5.7) 2.3 (1.4 to 3.9)
3.3 (2.1 to 4.8) 1 (reference) 1 (reference)
5.0 (2.9 to 8.1) 1.7 (0.9 to 3.3) 1.5 (0.7 to 3.2)
4.7 (2.6 to 7.6) 1.6 (0.8 to 3.3) 1.4 (0.7 to 3.1)
6.3 (1.6 to 15.4) 2.2 (0.7 to 7.4) 2.0 (0.6 to 6.9)
4.2 (2.9 to 5.8) 1 (reference) 1 (reference)
5.0 (2.8 to 7.9) 1.3 (0.7 to 2.4) 0.9 (0.5 to 1.8)
5.0 (2.8 to 7.9) 1.1 (0.5 to 2.2) 0.8 (0.4 to 1.6)
3.2 (1.6 to 5.7) 2.5 (0.9 to 7.0) 1.8 (0.6 to 5.3)
Table 3 Five-year results for death, myocardial infarction, and stroke by AKI status in the matched cohort
Events Number at period start One-year risk Five-year risk Hazard ratio
Endpoint n n % (95% CI) % (95% CI) (95% CI)
Death
Non-AKI 48 257 2.7 (1.3 to 5.6) 18.7 (14.5 to 24.1) 1 (reference)
AKI 66 257 9.3 (6.4 to 13.6) 25.7 (20.8 to 31.5) 1.6 (1.1 to 2.4)
Myocardial infarction
Non-AKI 7 242 0.4 (0.0 to 2.1) 2.9 (1.3 to 5.6) 1 (reference)
AKI 11 248 1.6 (0.5 to 3.8) 4.4 (2.4 to 7.5) 1.1 (0.4 to 3.2)
Stroke
Non-AKI 17 252 3.2 (1.5 to 5.9) 6.7 (4.1 to 10.3) 1 (reference)
AKI 10 252 2.0 (0.8 to 4.3) 4.0 (2.0 to 6.9) 0.5 (0.2 to 1.2)
AKI, Acute Kidney Injury; CI, Confidence Interval.
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between AKI and death towards a lower risk of death
among AKI patients. Furthermore, the inclusion of acute
patients will tend towards a higher proportion of pa-
tients developing AKI. However, the HR estimate was in
concordance with our findings (adjusted HR of 1.6 (95%
CI: 1.1 to 2.2). Tsai et al. studied the long-term impact
of RIFLE-defined AKI after surgery for aortic dissection.
AKI occurred in 135 (52.7%) of 256 patients and they
found an adjusted one-year HR for death of 2.6 (95% CI:
1.0 to 6.3) [7]. Finally, Gallagher et al. found in a pro-
pensity score matched cohort an adjusted five-year HR
for death of 1.52 (95% CI: 1.19 to 1.93) after CABG [5].
Interestingly, we found a high prevalence of AKI stage

























Figure 3 Kaplan Meier curve illustrating the five-year risk of death inincrease in creatinine was associated with an increase in
long-term mortality (HR 1.4 (95% CI: 1.0 to 2.1)).
Suggested short- and long-term pathophysiologic
mechanisms between AKI and cardiovascular events in-
clude fluid retention leading to unstable heart function
and inflammation leading to apoptosis and fibrosis at
the cardiac level [20,21]. It is known that chronic kidney
disease increases the risk of adverse cardiac events [22].
However, whether the effect of AKI is mediated by the
development of chronic kidney disease is still not evi-
dent and ideally requires prospective and regular meas-
urement of creatinine after discharge. Clinical studies of
adverse cardiac events after AKI is sparse and no studies
have used time-to-event analysis to examine the prog-
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* Patients can be registered with more than one cause of death
Figure 4 Causes of death by AKI status.*
Hansen et al. Critical Care 2013, 17:R292 Page 8 of 10
http://ccforum.com/content/17/6/R292in cardiac surgical patients. The aforementioned study
by Tsai et al. found a higher risk of major adverse car-
diac events after one year among AKI patients (40% (54
of 135)) compared with non-AKI patients (15% (18 of
121)) [7]. Similarly, they found a higher risk of stroke
among AKI patients. Studies of patients undergoing cor-
onary angiography and percutaneous coronary inter-
vention have also found a substantially higher risk of
myocardial infarction during long-term follow-up [23-25].
This indicates that the long-term prognostic impact of
AKI appears consistent, although the prevalence of AKI
differs according to population under study.
Strengths and limitations
The strengths of our study include a well-defined study
population with uniform access to health care which
minimizes selection bias. Our study population consisted
of solely elective surgical patients, thereby making a
homogenous cohort of patients. It is, therefore, reason-
able to assume that the patients’ pre-conditions and im-
mediate risks of AKI were more alike than if the study
population also included acute patients. We had complete
pre-operative plasma creatinine measurements as an esti-
mate of baseline kidney function and due to the elective
properties of the study population, this measured baseline
creatinine was reliable as a good estimate of the patients’
real baseline level. Furthermore, we had detailed pre-,
peri- and post-operative data.
We were not able to include all patients undergoing
surgery in the study period, but patient screening and
recruitment was done by a project nurse whose workingschedule was independent of which patients were on the
surgery schedule for the day, hence minimizing selection
bias. Furthermore, the urine output criteria were not ap-
plied to determine AKI status.
We defined the outcomes myocardial infarction and
stroke by ICD-10 codes. The positive predictive value
was above 92% for myocardial infarction and 80% for
stroke [26,27]. Overall, these indicate that we encountered
few false positive outcomes; hence risk of information bias
was limited. However, if present, this misclassification
would presumably be non-differential, and bias the associ-
ation towards unity.
Due to lack of registration of an exact event date, a
patient receives the code of diagnosis at hospital dis-
charge. For the purpose of a causal interpretation be-
tween AKI and MI/stroke, we only encountered the
myocardial infarction/stroke cases if the outcome of
interest occurred after discharge from the index admis-
sion for surgery. Meaning, we excluded all patients
with an outcome during the index admission for sur-
gery. In this manner we assured that the outcome oc-
curred after the AKI, which is required for a causal
interpretation.
For every patient follow-up began on the fifth post-
operative day. Due to the definition of the outcomes for
myocardial infarction/stroke (only encountering outcomes
at a new hospitalization after the index admission for sur-
gery) an immortal person-time bias was introduced, where
the object of study was not able to experience an outcome
[28]. Particularly, this may be the case for patients with
long hospitalizations. Our estimates may, therefore, be
Hansen et al. Critical Care 2013, 17:R292 Page 9 of 10
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stay for AKI patients was only seven days and five days for
non-AKI patients.
When adjusting for propensity scores and propensity
score matching we were able to control for the potential
confounding caused by the covariates included in the
propensity score, that is, patient-related factors, life-style
factors, disease history and surgery-related factors. Still,
we cannot exclude the possibility of residual or un-
measured confounding. However, we do believe that
we have addressed the most important confounders in
our analyses.
Finally, our study population was of limited size; thus,
some of our estimates are accompanied by broad confi-
dence intervals.
Clinical perspectives
This study demonstrates the impact of early post-
operative AKI on mortality, specifically in elective pa-
tients without pre-operative severe kidney disease. This
finding should encourage initiatives towards developing
prophylactic strategies for patients who develop even
mild reductions in kidney function. However, the risk of
myocardial infarction and stroke is still uncertain after
this study. Whether the potentially increased risk reflects
the effect of AKI or whether AKI acts as a marker of
vulnerability remain unclear. The study is most likely
generalizable throughout the setting of elective cardiac
surgery.
Conclusion
AKI following elective cardiac surgery was associated
with increased five-year mortality, and the risk increased
with increasing AKI stage. Although statistically impre-
cise, AKI may be associated with an increased risk of
myocardial infarction, but there was no association with
the risk of stroke.
Key messages
 More than one out of four elective cardiac surgery
patients developed AKI within the first five days
after cardiac surgery.
 AKI following elective cardiac surgery was
associated with increased five-year mortality.
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